Author:
Couselo-Rodríguez C.,Batalla A.,Carrascosa J.M.,Chicharro P.,González-Quesada A.,de la Cueva P.,Giménez-Arnau A.M.,Gilaberte Y.,Rodríguez-Serna M.,Montero-Vilchez T.,Ruiz-Villaverde R.,Elosua-González M.,Silvestre-Salvador J.F.,Munera-Campos M.,Sánchez-Pérez J.,Carretero G.,Mauleón-Fernández C.,Curto-Barredo L.,Ballano-Ruiz A.,Botella-Estrada R.,Arias-Santiago S.,Navarro-Triviño F.J.,Roustan-Gullón G.,Betlloch I.,del Alcázar E.,Abalde-Pintos M.T.,Suárez-Perez J.,García-Doval I.,Descalzo M.Á.,Flórez Á.
Reference20 articles.
1. Drug survival of dupilumab compared to cyclosporin in moderate-to-severe atopic dermatitis patients;Dal Bello;Dermatol Ther,2020
2. Counting the Burden: Atopic Dermatitis and Health-related Quality of Life;Ali;Acta Derm Venereol,2020
3. Atopic dermatitis and psychosocial comorbidities;Kage;J Dtsch Dermatol Ges,2020
4. Clinical and Economic Burden of Mild-to-Moderate Atopic Dermatitis in the UK: A Propensity-Score-Matched Case-Control Study;Toron;Dermatol Ther (Heidelb),2021
5. BIFIMED: Buscador de la Información sobre la situación de financiación de los medicamentos. [consulted on April 29, 2023]. Available from https://www.sanidad.gob.es/gl/profesionales/medicamentos.do